126 related articles for article (PubMed ID: 28034513)
1. Suppression of the acute upregulation of phosphorylated-extracellular regulated kinase in ventral tegmental area by a μ-opioid receptor agonist is related to resistance to rewarding effects in a mouse model of bone cancer.
Nakamura A; Ono H; Ando A; Hinata M; Niidome K; Omachi S; Sakaguchi G; Shinohara S
J Pharmacol Sci; 2017 Jan; 133(1):9-17. PubMed ID: 28034513
[TBL] [Abstract][Full Text] [Related]
2. Role of extracellular signal-regulated kinase in the ventral tegmental area in the suppression of the morphine-induced rewarding effect in mice with sciatic nerve ligation.
Ozaki S; Narita M; Narita M; Ozaki M; Khotib J; Suzuki T
J Neurochem; 2004 Mar; 88(6):1389-97. PubMed ID: 15009639
[TBL] [Abstract][Full Text] [Related]
3. Effect of estrogen on morphine- and oxycodone-induced antinociception in a female femur bone cancer pain model.
Ono H; Nakamura A; Kanemasa T; Sakaguchi G; Shinohara S
Eur J Pharmacol; 2016 Feb; 773():1-12. PubMed ID: 26802873
[TBL] [Abstract][Full Text] [Related]
4. Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2.
Ozaki S; Narita M; Narita M; Iino M; Miyoshi K; Suzuki T
Neuroscience; 2003; 116(1):89-97. PubMed ID: 12535942
[TBL] [Abstract][Full Text] [Related]
5. Differential activation of the μ-opioid receptor by oxycodone and morphine in pain-related brain regions in a bone cancer pain model.
Nakamura A; Hasegawa M; Minami K; Kanbara T; Tomii T; Nishiyori A; Narita M; Suzuki T; Kato A
Br J Pharmacol; 2013 Jan; 168(2):375-88. PubMed ID: 22889192
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of morphine-induced antinociception by harmaline: involvement of μ-opioid and ventral tegmental area NMDA receptors.
Alijanpour S; Zarrindast MR
Psychopharmacology (Berl); 2020 Feb; 237(2):557-570. PubMed ID: 31740992
[TBL] [Abstract][Full Text] [Related]
7. Low doses of dextromethorphan attenuate morphine-induced rewarding via the sigma-1 receptor at ventral tegmental area in rats.
Chen SL; Hsu KY; Huang EY; Lu RB; Tao PL
Drug Alcohol Depend; 2011 Sep; 117(2-3):164-9. PubMed ID: 21320758
[TBL] [Abstract][Full Text] [Related]
8. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
[TBL] [Abstract][Full Text] [Related]
9. Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area.
Ozaki S; Narita M; Narita M; Iino M; Sugita J; Matsumura Y; Suzuki T
J Neurochem; 2002 Sep; 82(5):1192-8. PubMed ID: 12358766
[TBL] [Abstract][Full Text] [Related]
10. Exposure to opiates in female adolescents alters mu opiate receptor expression and increases the rewarding effects of morphine in future offspring.
Vassoler FM; Wright SJ; Byrnes EM
Neuropharmacology; 2016 Apr; 103():112-21. PubMed ID: 26700246
[TBL] [Abstract][Full Text] [Related]
11. Role of MEK-ERK pathway in morphine-induced conditioned place preference in ventral tegmental area of rats.
Lin X; Wang Q; Ji J; Yu LC
J Neurosci Res; 2010 May; 88(7):1595-604. PubMed ID: 20091775
[TBL] [Abstract][Full Text] [Related]
12. Blockade of orexin-1 receptors in the ventral tegmental area could attenuate the lateral hypothalamic stimulation-induced potentiation of rewarding properties of morphine.
Zarepour L; Fatahi Z; Sarihi A; Haghparast A
Neuropeptides; 2014 Jun; 48(3):179-85. PubMed ID: 24793540
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of changes in the morphine-induced pharmacological actions under chronic pain-like state: suppression of dopaminergic transmission in the brain.
Narita M; Suzuki M; Imai S; Narita M; Ozaki S; Kishimoto Y; Oe K; Yajima Y; Yamazaki M; Suzuki T
Life Sci; 2004 Apr; 74(21):2655-73. PubMed ID: 15041447
[TBL] [Abstract][Full Text] [Related]
14. Effect of a selective GABA(B) receptor agonist baclofen on the mu-opioid receptor agonist-induced antinociceptive, emetic and rewarding effects.
Suzuki T; Nurrochmad A; Ozaki M; Khotib J; Nakamura A; Imai S; Shibasaki M; Yajima Y; Narita M
Neuropharmacology; 2005 Dec; 49(8):1121-31. PubMed ID: 16095635
[TBL] [Abstract][Full Text] [Related]
15. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
[TBL] [Abstract][Full Text] [Related]
16. The contribution of Gi/o protein to opioid antinociception in an oxaliplatin-induced neuropathy rat model.
Kanbara T; Nakamura A; Takasu K; Ogawa K; Shibasaki M; Mori T; Suzuki T; Hasegawa M; Sakaguchi G; Kanemasa T
J Pharmacol Sci; 2014; 126(3):264-73. PubMed ID: 25346041
[TBL] [Abstract][Full Text] [Related]
17. Enhanced GABAergic synaptic transmission at VLPAG neurons and potent modulation by oxycodone in a bone cancer pain model.
Takasu K; Ogawa K; Nakamura A; Kanbara T; Ono H; Tomii T; Morioka Y; Hasegawa M; Shibasaki M; Mori T; Suzuki T; Sakaguchi G
Br J Pharmacol; 2015 Apr; 172(8):2148-64. PubMed ID: 25521524
[TBL] [Abstract][Full Text] [Related]
18. Brain regional Fos expression elicited by the activation of mu- but not delta-opioid receptors of the ventral tegmental area: evidence for an implication of the ventral thalamus in opiate reward.
David V; Matifas A; Gavello-Baudy S; Decorte L; Kieffer BL; Cazala P
Neuropsychopharmacology; 2008 Jun; 33(7):1746-59. PubMed ID: 17895918
[TBL] [Abstract][Full Text] [Related]
19. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area.
Rezayof A; Nazari-Serenjeh F; Zarrindast MR; Sepehri H; Delphi L
Eur J Pharmacol; 2007 May; 562(1-2):92-102. PubMed ID: 17336285
[TBL] [Abstract][Full Text] [Related]
20. Effect of the norepinephrine transporter (NET) inhibition on μ-opioid receptor (MOR)-induced anti-nociception in a bone cancer pain model.
Ono H; Nakamura A; Kanbara T; Minami K; Shinohara S; Sakaguchi G; Kanemasa T
J Pharmacol Sci; 2014; 125(3):264-73. PubMed ID: 24965165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
